TGI Life Sciences

I'm seeking a Senior Vice President /VP of Business Development for one of my clients. This global public biotech and CRO company operates as a drug discovery research platform for small molecules and has acquired another leading company in structure-based drug discovery in Europe. ❗ ✉ Email me ssun@tgilifesciences.com if you are interested in knowing about this opportunity. ❗ 🖇 Message me via LinkedIn. As a recruiter, yes, I always target candidates, but this is a tremendous commercial leadership opportunity, and we are open to talking! Please drop me a message or catch up if you think you could be suited for this role for anyone in your network. Let's start a conversation soon and get you to this opportunity! #Pharmacutical #Biotech #CRO #CDMO

💊 I can't help but feel optimistic about the biotech industry next year.... There is no denying it has been a really tough 18 months for the industry, but I've started writing my business plan for next year and I'm being filled with optimism. Here's my 2 pence on why.... 2020/2021 was an incredible year, but you could argue there was "over investment" into the industry, record breaking series A that were making redundancies a year later etc. That created a far more cautious approach to investment and throw in the global economic climate and fundraising or IPO's became near on impossible for early stage biotech (regardless of the quality of data). I heard a stat somewhere that the amount of money invested into the industry in 2023 wasn't too dissimilar to 2020 however, it was all going to Series C, which shows the risk aversion to investment. But don't quote me on that. So why am I now optimistic about next year?... Firstly, as recruiters call it - the "job flow" is increasing - this is the amount of roles a recruiter is working on at any given time. Showing a steady increase into the appetite to hire. Secondly, the financial market in the industry continues to bounce back. IPO’s increased in Q1 2024 with $3.72b raised, which is more than 6 times that of Q4 2023, and higher than every other quarter in 2023. The total IPO amount raised in 2023 was $4.4b, compared to a high of $30.8b in 2020. Thirdly, the federal rate cut which is the first in 4 years (see a trend here?). This will play a major part in the economical landscape for the industry. I'll be interested to see the investment figures over Q4 this year, but 2024 is already better than 2023. What are your thoughts/outlook for 2025?

📽 I recently had a virtual sit-down with my industry friend, Ron Carter, Chief Medical Officer at Microbiotica . Ron and Myself have known each other since we worked together on his joining of Microbiotica, and have kept in touch since. 🔬 We delved into the current industry landscape, the world of Microbiomes, and invaluable insights on navigating the turbulent investment market. ✏ There is also some really useful pointers from Ron on things to consider when deciding your next career move. Thanks again for your time Ron, it's always a pleasure. If you're curious to learn more, watch our conversation! ✅ Feel free to reach out if you have specific questions or topics you might want to discuss. #Biotechnology #Microbiome #InvestmentStrategy #CareerDevelopment #MedicalIndustry #HealthTech #LeadershipInsights #Networking

🎊 𝐂𝐨𝐧𝐠𝐫𝐚𝐭𝐮𝐥𝐚𝐭𝐢𝐨𝐧𝐬 𝐨𝐧 7 𝐲𝐞𝐚𝐫𝐬 𝐚𝐭 TGI Life Sciences Karl Paddley! 💚 Your exceptional dedication and vision have been truly inspiring. Here's to your continued success! 🔔 𝙋𝙨𝙨.. 𝙔𝙤𝙪 𝙝𝙖𝙫𝙚 5 𝙐𝙣𝙧𝙚𝙖𝙙 𝙈𝙚𝙨𝙨𝙖𝙜𝙚𝙨 #Leadership #Achievement #ProfessionalGrowth #BusinessSuccess #InnovativeThinking

⛔ This one is open to both recruiters and hiring managers ⛔ What percentage of roles do you either hire for, or recruit for are filled by candidates that have 100% of the requirements? TGI Life Sciences #hiring #biotech #pharma #pharmaceutical #jobseekers #jobs #recruitment #cv #resume